MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis

Imaging genomics in cancer research: limitations and promises

(2016) Harrison X Bai et al.   BRITISH JOURNAL OF RADIOLOGY

The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers

(2016) Ivayla Apostolova et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas

(2016) Panagiotis Korfiatis et al.   MEDICAL PHYSICS

Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models

(2016) Philipp Kickingereder et al.   RADIOLOGY

Imaging in the Age of Precision Medicine: Summary of the Proceedings of the 10th Biannual Symposium of the International Society for Strategic Studies in Radiology

(2016) Christian J. Herold et al.   RADIOLOGY

Treatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experience

(2016) Shuping Xu et al.   Oncotarget

GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity

(2016) Olle R. Lindberg et al.   Oncotarget

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

(2015) Dawn Q Chong et al.   BMC CANCER

Tumor border sharpness correlates with HLA-G expression in low-grade gliomas

(2015) Yinyan Wang et al.   JOURNAL OF NEUROIMMUNOLOGY

Arterial Spin-Labeling Perfusion MRI Stratifies Progression-Free Survival and Correlates with Epidermal Growth Factor Receptor Status in Glioblastoma

(2014) X.J. Qiao et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Mapping p53 Mutations in Low-Grade Glioma: A Voxel-Based Neuroimaging Analysis

(2014) Y. Y. Wang et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas

(2014) Yinyan Wang et al.   NEURORADIOLOGY

Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients

(2014) B.K.M. Reddy et al.   ORAL ONCOLOGY

Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification

(2014) A. Gupta et al.   Clinical Neuroradiology

Tumor blood flow from arterial spin labeling perfusion MRI: A key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas

(2013) Roh-Eul Yoo et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy.

(2012) Mayra Ramos-Suzarte et al.   CANCER BIOLOGY & THERAPY

Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma

(2012) Elana S. Tykocinski et al.   NEURO-ONCOLOGY

MRI-coupled Fluorescence Tomography Quantifies EGFR Activity in Brain Tumors

(2010) Scott C. Davis et al.   ACADEMIC RADIOLOGY

Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR

(2010) Chetana Basavaraj et al.   CANCER BIOLOGY & THERAPY

Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck

(2010) Marta Osorio Rodríguez et al.   CANCER BIOLOGY & THERAPY

Molecular markers in gliomas: impact for the clinician

(2010) Silvia Hofer et al.   Targeted Oncology

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging

(2009) Sylvia Drabycz et al.   NEUROIMAGE